miR-122, IL28B Genotype and the Response to Interferon in Chronic Hepatitis C Virus Infection

Nature Reviews Immunology - United Kingdom
doi 10.1038/nri3463-c1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Importance of IL28B Polymorphism in Response to Pegylated Interferon Α and Ribavirin in Chronic Hepatitis Caused by HCV Genotype 1b

Przeglad Gastroenterologiczny
Gastroenterology
2012English

KIR, HLA, and IL28B Variant Predict Response to Antiviral Therapy in Genotype 1 Chronic Hepatitis C Patients in Japan

PLoS ONE
Multidisciplinary
2013English

Cellular Immunity to Hepatitis C Virus Core Protein and the Response to Interferon in Patients With Chronic Hepatitis C

Hepatology
MedicineHepatology
1998English

Serum Interferon-Related MicroRNAs as Biomarkers to Predict the Response to Interferon Therapy in Chronic Hepatitis C Genotype 4

PLoS ONE
Multidisciplinary
2015English

Dysregulation of Innate Immunity in Hepatitis C Virus Genotype 1 IL28B-unfavorable Genotype Patients: Impaired Viral Kinetics and Therapeutic Response

Hepatology
MedicineHepatology
2012English

miR-122 and the Hepatitis C RNA Genome

RNA Biology
Cell BiologyMolecular Biology
2013English

Vitamin D Levels and IL28B Polymorphisms Are Related to Rapid Virological Response to Standard of Care in Genotype 1 Chronic Hepatitis C

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

Interleukin-6 Haplotypes and the Response to Therapy of Chronic Hepatitis C Virus Infection

Genes and Immunity
ImmunologyGenetics
2009English

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy